Eight (08) new cane varieties have been registered with the Federal Seed Certification and Registration (FSCR) Department, Islamabad as an initial step towards formal variety approval for commercial cultivation.
Furthermore, complete data for two primary candidates—S-2010 CPSG-2525 and S-2013 SLSG-1283—has been completed under the National Uniform Varietal Yield Trials (NUVYT). Both varieties have successfully performed the Distinctness, Uniformity, and Stability (DUS) test for two consecutive years.
High-yielding, high-sugar recovery proprietary varieties bred and field-tested at SSRI.
SLSG-1283 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
CP-1101 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
SLSG-483 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
SLSG-109 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
CPTJ-349 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
SLSG-1591 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
CPSG-2525 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
CPSG-29 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
CPSG-153 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.
SLSG-128 Proprietary SSRI clone tested for disease resistance, cane weight, and high sucrose extraction capability.